Neuroprotective Effects of Selective Serotonin Reuptake Inhibitors
Received Date: Jan 09, 2018 / Accepted Date: Jan 23, 2018 / Published Date: Jan 30, 2018
Serotonin reuptake inhibitors (SSRIs) have been suggested to have a neuroprotective effect. This claim is is largely clinical and not previously supported by evidence based data. This area of neuroscience has not been well studied at the cellular level. This study offers a three part laboratory examination of the effect of SSRIs on glia cells. The investigation found that serotonin reuptake inhibitors had a detectable protective effect on glia when tested under various classic methods. The examination of cell morphology, use of vital dyes, cell death and growth rates were consistent with a neuroprotective class effect. The data suggest that serotonin reuptake inhibitors are, in fact neuroprotective at normal physiologic dosages.
Keywords: Neuroprotective; Serotonin; Glia neuron
Citation: Wilcox JA (2018) Neuroprotective Effects of Selective Serotonin Reuptake Inhibitors. J Mol Immunol 3: 118.
Copyright: © 2018 Wilcox JA. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Select your language of interest to view the total content in your interested language
Share This Article
Open Access Journals
- Total views: 1596
- [From(publication date): 0-2018 - Oct 19, 2021]
- Breakdown by view type
- HTML page views: 1361
- PDF downloads: 235